Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
05:38:20 EDT Sun 20 Jul 2025
Enter Symbol
or Name
USA
CA



Z:CHRO - CHANNEL THERAPEUTICS CORPORATION - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CHRO - ZHALTED1.35    3.80  0.45Jul 01Jul 1015 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-07-10 08:00U:CHRONews ReleasePelthos Therapeutics Launches ZELSUVMI(TM) (berdazimer) Topical Gel 10.3%, the First and Only FDA-Approved At-Home Treatment for Molluscum Contagiosum
2025-07-02 07:00U:CHRONews ReleasePelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement
2025-06-27 09:15U:CHRONews ReleaseChannel Therapeutics Announces Reverse Common Stock Split in Conjunction with the Close of the Merger with Pelthos Therapeutics and Concurrent $50.1 Million Private Placement
2025-05-14 08:00U:CHRONews ReleaseChannel Therapeutics Announces Positive Efficacy Results for the Treatment of Eye Pain Using its NaV1.7 Inhibitor in Multiple Preclinical In Vivo Models
2025-05-01 17:00U:CHRONews ReleaseChannel Therapeutics Provides Announcement on 2024 Annual Report to Comply with NYSE American Listing Rules
2025-04-17 06:00U:CHRONews ReleaseLigand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics
2024-12-20 09:00U:CHRONews ReleaseChannel Therapeutics Highlights Differences Between NaV1.7 and NaV1.8 in Light of Recent Clinical Data on Suzetrigine
2024-12-18 08:30U:CHRONews ReleaseChannel Therapeutics Announces Positive Efficacy Data For a Depot Formulation of a NaV1.7 Inhibitor in a Preclinical In Vivo Nerve Block Model
2024-11-21 09:49U:CHRONews ReleaseChromocell Announces Name Change to "Channel Therapeutics Corporation" and Provides Therapeutic Program Updates
2024-10-29 08:30U:CHRONews ReleaseChromocell Announces Unveiling of Injectable Depot Program for the Treatment of Surgical Pain
2024-10-28 08:00U:CHRONews ReleaseChromocell to Present at Upcoming Fall Investor Conferences
2024-10-24 08:45U:CHRONews ReleaseChromocell Announces Amendment to Stock Repurchase Plan
2024-09-16 08:35U:CHRONews ReleaseChromocell to Participate in Life Sciences Investor Forum September 19th
2024-09-03 09:00U:CHRONews ReleaseChromocell to Present at the H.C. Wainwright 26th Annual Global Investment Conference
2024-08-07 08:45U:CHRONews ReleaseChromocell Announces Stock Repurchase Plan